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SUMMARY 
Peri-operative antibiotics are often used by both veterinarians and physicians to prevent and 
treat surgical site infections (SSI). According to international guidelines, antibiotic prophylaxis 
is only required when it has been proven to be clinically necessary. Surgeries with no indication 
for prophylactic treatment with antibiotics include routine procedures such as cutaneous and 
superficial soft tissue surgeries and clean abdominal procedures. 
The risk for developing SSI depends not only on external factors such as contamination of the 
surgical area but also on the patient’s health status and possible concurrent diseases such as e.g. 
diabetes. 
Mammary tumours are the most common type of tumour to afflict female dogs. Thus, 
mastectomy is a common procedure and, in most cases, the gold standard for treatment. 
Depending on the size, location and invasiveness of the tumour, or tumours, different surgical 
approaches are available.  
Mastectomy is usually a clean surgery. However, it can be a large reconstructive surgery due 
to the necessity to remove extensive amounts of tissue to achieve safety margins. Therefore, 
this procedure can have an increased risk for complications. 
According to the literature, SSI rates in clean surgeries range between 0-6%. In the majority of 
the studies referred to, patients submitted for clean surgical procedures receive pre-operative 
antibiotics. This makes comparison of SSI rates unreliable. Moreover, to the best of the authors 
knowledge, there are no prior studies supporting the use of antibiotics in canine mastectomy. 
This study included 65 separate surgeries, performed on 59 female dogs. This resulted in 95 
separate surgical wounds. The surgeries ranged from lumpectomies to radical mastectomies. 
Information concerning post-operative complications (i.e. SSI) were obtained from medical 
records. 
Patients treated with pre-operative antibiotics and/or cortocosteroids were excluded (n=7). 
Complications reported were divided into; seroma, infection, suture reaction, 
dehiscensce/wound rupture and other. 
The total incidence of complications was 20% (n=19/95), whereas SSI rates was 7.4% (n=7/95). 
These results were similar to previously observed rates in studies analysing SSI rates in clean, 
surgical procedures receiving pre-operative antibiotics. In conclusion, this study provides no 
support for the use of perioperative antibiotics in mastectomy in otherwise healthy dogs. 
  
  
SAMMANFATTNING 
Peri-operativ antibiotika används ofta av både veterinärer och läkare för att förhindra och 
behandla post-operativa sårinfektioner (SSI). Enligt internationella riktlinjer, skall antibiotika 
endast användas i ett profylaktiskt syfte när det är bevisat att det är kliniskt nödvändigt. 
Operationer utan indikation för profylaktisk antibiotikaterapi inkluderar rutiningrepp så som 
hud- och ytliga mjukdelsoperationer samt rena bukingrepp. 
Risken att utveckla SSI grundar sig inte endast i påverkan från yttre faktorer såsom exempelvis 
kontamination av det kirurgiska området. Risken beror även på patientens hälsostatus och 
eventuella samtidiga sjukdomar såsom exempelvis diabetes. 
Juvertumörer är den vanligaste tumörformen som drabbar tikar. På grund av detta är även 
mastektomi en vanlig operation, och i de flesta fall, den rekommenderade behandlingen. 
Beroende på storlek, lokalisation och eventuell infiltration av omliggande vävnader finns olika 
kirurgiska tillvägagångssätt. 
Mastektomi är ett ingrepp vilket klassas som rent. Det kan dock inkludera omfattande 
rekonstruktion då det kan vara nödvändigt att avlägsna avsevärda mängder vävnad för att uppnå 
rena marginaler. Därmed ökar risken för komplicerad sårläkning. 
Enligt literaturen är förekomsten av SSI, vid rena operationer, mellan 0-6%. I majoriteten av de 
studier som refereras till, har patienter som fått ren kirurgi utförd behandlats med pre-operativ 
antibiotika. Detta gör jämförelser med studier som denna, där det inte används, otillförlitliga. 
Vidare så saknas det, till författarens kännedom, tidigare studier som stödjer användningen av 
antibiotika vid mastektomier hos hundar. 
I denna studie inkluderades 65 separata operationer utförda på 59 tikar. Detta resulterade i 95 
separata kirurgiska sår. Operationerna varierade från lumpektomier till radikala mastektomier. 
Information gällande post-operativa komplikationer (d.v.s. SSI) erhölls från patientjournaler. 
Inga patienter som blivit behandlade med pre-operativ antibiotika inkluderades. 
Komplikationer som rapporterades delades in i; serom, infektion, suturreaktion, 
sårruptur/öppning och övriga. 
Den totala förekomsten av komplikationer var 20% (n=19/95), och förekomsten av SSI var 
7.4% (n=7/95). 
Dessa resultat liknar tidigare observerade resultat gällande förekomst av SSI i studier där 
patienter blivit behandlade med pre-operativ antibiotika vid kirurgiska ingrepp klassade som 
rena. 
Sammanfattningsvis, visar denna studie inget stöd för profylaktisk antibiotikanavändning vid 
mastektomier på för övrigt friska hundar finns. 
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INTRODUCTION 
Background 
Antimicrobial prophylaxis is commonly used by veterinarians, and physicians, for various 
surgical procedures to treat and prevent surgical site infection (SSI). SSI remain an important 
cause for post-operative morbidity (Nelson, 2011). Increasing antimicrobial resistance is a 
major, worldwide public health challenge that requires strict policies and guidelines concerning 
the use of antibiotics. 
According to international guidelines, antibiotic prophylaxis is only recommended when it has 
been proven to be clinically necessary. Surgeries with no indication for antibiotic prophylaxis 
include routine procedures such as cutaneous and superficial soft tissue procedures and clean 
abdominal procedures (Scottish Intercollegiate Guidelines Network, 2014). The risk of 
developing SSI largely depends on the extent of wound contamination with exogenous bacteria 
(Mangram et al. 1999; Sveriges veterinärförbund, 2009). Efficient pre-operative preparation of 
the patient’s skin preparation and the used surgical technique can reduce the number of wound 
contaminants (Mangram et al 1999; Sveriges veterinärförbund, 2009; Windahl et al. 2015). In 
most cases mastectomy is the current gold standard of therapy for mammary tumours in dogs 
(Bartels et al., 1978; Novosad et al., 2003; Kudnig et al., 2012). The dimensions of the surgical 
excision are based on the size and location of the primary tumour and lymphatic drainage 
(Kudnig et al., 2012). Mastectomy is classified as a skin and reconstructive procedure. Peri-
operative antimicrobial therapy is commonly used, due to frequent surgical complications 
including SSI during skin and reconstructive surgery (Field et al., 2015; Montinaro et al., 2015). 
However, there are no studies supporting its benefits in mastectomies. To the best of the 
author’s knowledge, there are no prior publications establishing guidelines for the use of 
antibiotics in canine mastectomy. 
In neither Swedish or international guidelines for the use of antibiotics are there clear guidelines 
for the use of antibiotics in connection to mastectomy described (Sveriges veterinärförbund, 
2009; Spohr et al., 2009; Scottish Intercollegiate Guidelines Network, 2014). 
The author sought to determine whether antibiotic prophylaxis affected rates of SSI in canine 
mastectomy.  
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LITERATURE REVIEW 
Reconstructive surgery 
Mastectomies can lead to large skin defects that require reconstruction. Techniques used in 
reconstructive surgery can include: skin stretching, skin recruitment, free skin grafts, 
microvascular free tissue transfer and a variety of skin flaps (Nevill et al., 2010). When 
compared with humans, the higher mobility and elasticity of dog’s skin can facilitate 
performing reconstructive surgery (Hunt et al., 2001). But since mammary tumour removal can 
include the removal of large areas of tissue, the risk for complications should be heeded (Table 
1 and Table 2) (De Carvalho Vasconcellos et al., 2005; Field et al., 2015; Montinaro et al., 
2015; Horta et al., 2015). The goal of reconstructive surgery is to achieve wound healing and 
reestablishment of normal function of the skin (Amsellem, 2011). 
When performing reconstructive surgery to cover an area, the surrounding skin is detached 
(undermined) from underlying tissues in order to be able to stretch the skin so that it can cover 
the defect (Szentimrey, 1998; Hunt et al. 2001; Amsellem, 2011). By undermining the skin, the 
surgeon is left with varying amounts of dead space (Amsellem, 2011). This may be corrected 
during surgery (through e.g. use of walking sutures) and can reduce the risk for complications 
(Remedios, 1999).  
 
Table 1. Incidence of complications in reconstructive surgery (including wounds classified as clean, 
clean-contaminated, contaminated and dirty) (adapted and summarized from: Field et al., 2015; 
Montinaro et al., 2015) 
Complication Incidence (%) 
Dehiscence 18-50 
Swelling of skin flap (axial pattern)  43 
Necrosis  18-46 
Infection 12 
Discharge 14 
Seroma 23 
 
Table 2. Post-operative complication rates (regional(n=18) and radical mastectomy (n=18) 10 days 
after surgery) (Adapted from: Horta et al, 2015) 
Complication  Regional (%) Radical (%) 
Posterior limb edema 22 11 
Hematoma 66 50 
Dehiscence 11 22 
Subcutanoeus emphysema 11 5,5 
Infection 22 50 
Seroma 5,5 0 
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Complications in reconstructive surgery 
Seroma 
Seroma is the accumulation of serosanguineous fluids within a dead space (Amsellem, 2011). 
This accumulation of fluids is formed by vascular leakage which is caused by the post-operative 
inflammation and also due to capillary bleeding (Amsellem, 2011). To minimise the risk of 
seroma formation, gentle tissue handling, fastidious haemostasis and closure of dead space is 
of importance (Remedios, 1999). In general, seromas are not painful (Remedios, 1999). They 
can often be differentiated from abscesses by clinical examination but if needed, a 
bacteriological culture can be of assistance (Amsellem, 2011). 
Aspiration is usually not recommended as treatment of seromas due to an increased risk of 
abscess formation through contamination (Pavletic, 2010). Although, in case of large seromas, 
aspiration may be necessary along with compression, but the risk of relapse is rather high 
(Pavletic, 2010). Treatment for seromas also include drainage, which can be achieved by 
removing solitary sutures to open up the wound, or inserting a drain (Amsellem, 2011). 
 
Hematoma 
Hematoma is a localized collection of blood outside the blood vessels (Amsellem, 2011). This 
is often the result of incomplete haemostasis (Amsellem, 2011). Hematomas, as well as 
seromas, can increase tension in the wound (Amsellem, 2011). Thus, they can increase the risk 
of wound rupture or dehiscence (Amsellem, 2011). Furthermore, the increased tension and 
pressure exerted by hematomas, can reduce the blood supply in the tissue which may increase 
the risk of necrosis (Hillelson et al., 1980). 
 
Contamination of adjacent tissues with neoplastic cells 
When removing tumours, such as mammary gland tumours, the risk of contamination of 
adjacent tissues by neoplastic cells should be considered (Amsellem, 2011). If it is not possible 
to remove the entire tumour, or tumours, with safety margins, there is an underlying risk for 
contamination (Amsellem, 2011). One technique of reconstructive surgery, related to tumour 
removal, includes removing the tumour in a two staged process (Amsellem, 2011). First, the 
tumour is removed and the wound is bandaged while the tumour is examined 
histopathologically and after this further excised to the extent necessary (Liptak et al., 2009).  
Another technique includes immediate reconstruction after the tumour has been removed 
(Seguin et al., 2005). When using this technique, gloves, instruments and drapes should be 
changed once the tumour is removed to prevent contamination (Seguin et al., 2005). 
 
Wound tension 
Tension in a wound creates a risk for wound rupture, or dehiscence, which is a common 
complication after reconstructive surgery (Amsellem, 2011). Tension in the wound can also 
cause tissue constriction which results in lymphatic and venous compression and consequently 
ischemia and necrosis (Lascelles et al., 2003; Amsellem, 2011). If, and when, swelling of tissue 
is seen, immediate intervention is necessary (Pavletic, 2010). To relieve the pressure that has 
built up, sutures can be removed (Pavletic, 2010). Alternatively, another incision, parallel to 
the original incision can be made (Pavletic, 2010). This is of particular importance in the distal 
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extremities where tissue tension can lead to a tourniquet effect which ultimately can lead to 
total occlusion of lymphatic and venous drainage (Lascelles et al., 2003). 
 
Skin flap necrosis 
A variety of skin flaps can be used during reconstructive surgery (Nevill, 2010). Depending on 
their blood supply skin flaps can be classified as either axial pattern (APF) or sub dermal flaps 
(Pavletic, 2002). Necrosis in a skin flap is commonly associated with a lack of blood supply 
and usually involves the tip (Amsellem, 2011). This type of necrosis is referred to as distal flap 
necrosis (Pavletic, 2002). 
When using a flap to cover an area, the skin used should be undermined below the cutaneous 
trunci muscle or under the deep subcutaneous tissue (Pavletic, 1982). This is done to preserve 
the sub dermal plexus that supplies the skin with blood (Pavletic, 1982). Stretching skin beyond 
its physical limits of blood supply and inadequate post-operative care may lead to necrosis and 
other complications as described above (Pavletic, 1982). 
 
Wound healing and post-operative care 
A wound goes through several stages in the process of healing (Campbell, 2015). Initially it 
goes through the inflammatory/debridement phase (Campbell, 2015). During this first stage, 
the white blood cells (WBCs) performs an autolytic debridement of the wound (Campbell, 
2015). Secondly, it goes through the proliferative/healing phase (Campbell, 2015). This phase 
consists of two separate, but simuoultaneus, processes: epithelialization and wound contraction 
(Campbell, 2015). The third, and last stage, is remodeling/maturation during which wound 
repair consists of remodeling and strengthening of collagen (Tobias et al., 2012; Campbell, 
2015).  
Removing mammary tumours is considered a clean surgery where the wound is closed with 
sutures to heal primarily. Wounds that are intended to heal primarily should have their edges 
well approximated and in direct contact (Yao et al., 2013). During the first phases of wound 
healing, the tensile strength in the wound is very limited (Yao et al., 2013). The wound is kept 
together by the sutures, as remodeling of collagen fibres have not yet occured (Yao et al., 2013). 
Because of the limited tensile strength, excessive movement in the surgical area should be 
avoided (Franz et al., 2008). 
Cleaning of a post-operative wound is occasionally necessary to remove debris, exudate or 
devitalised tissue that otherwise may delay healing (Velnar et al., 2009). When cleaning, 
caution should be taken to avoid inflicting trauma to the wound (Yao et al., 2013). It is also 
important to remember that cleaning itself may interfere with healing (Yao et al., 2013). 
Therefore, excessive cleaning may delay healing (Yao et al., 2013). 
In primary wound healing, dressing of the wound is optional. If a dressing is used it should 
promote wound healing, be able to remove exudate and be a barrier against contamination (Yao 
et al., 2013). Dressings should be left untouched for the first 48 hours and only removed if 
necessary. If so, an aseptic, non-touch technique should be used (National Institute for Health 
and Care Exellence, 2008). 
If a wound can not, or should not, be closed to heal by primary healing, it may be left open to 
heal by secondary healing. The majority of open wounds profit from healing in a moist 
environment (Campbell, 2015). A moist environment can support the normal cell function 
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during the different stages of the healing process (Campbell, 2015). To achieve moist 
environments, clinicians have a wide variety of moisture-retentive dressings (MRDs) to chose 
from (Campbell, 2015). MRDs can work synergistically with in particular open wounds to 
support microscopically precise debridement and repair and at the same time contribute to a 
faster, and healthier, healing process (Campbell, 2015). The choice of MRD is based on the 
needs of the wounds itself, as wounds can range from clean, surgical wounds to dirty, traumatic 
wounds (Campbell, 2015). The choice made, can be based on the need for debridement, the 
need for granulation or epithelialization and the amount of exudate the wound is expected to 
produce (Campbell, 2015). 
During the initial phase (inflammatory/debridement phase), the MRD chosen should support 
the debridement performed by the WBCs and also support the cytokines that signal for other 
cells involved in the healing process (Campbell, 2015). Apart from this, the dressing should 
also be able to absorb the exudate produced by the wound and generated by the debridement to 
maintain a healthy environment (Campbell, 2015). 
The MRD used during the proliferative/healing phase should support the growth and function 
of fibroblasts, endothelial and epithelial cells as these cells are responsible for granulation, 
epithelialization and contraction (Campbell, 2015). At this stage the MRD should also support 
growth factors and be able to absorb exudate and add moisture back to the wound (Campbell, 
2006; Junker et al., 2013; Maynet et al., 2014). 
 
Surgical site infections 
SSI can occur anywhere in the surgical area (Tobias et al., 2012). Standard criteria to divide 
SSI into incisional or organ/space infections have been developed (Horan et al., 1992). 
Incisional infections can be further subdivided into superficial or deep depending on if the 
infection is limited only to the skin and subcutanoeus tissues, or if it extends further and also 
involves deeper tissues such as the muscular fascia and muscular layers (Horan et al., 1992). 
Organ/space infections can occur anywhere in the body other than the skin, fascia or muscle 
that is involved in the surgical procedure (Horan et al., 1992). SSI is a relatively common 
occurrence in both human and veterinary medicine (Mangram et al., 1999; Nelson., 2011; 
Verwilghen et al., 2015). In veterinary medicine SSI afflict between 0%-26.8% (Table 3) of all 
patients that undergo surgery (Vasseur et al., 1985; 1988; Eugster et al., 2004; Fossum, 2009; 
Nelson, 2009a; 2011b; Tobias et al., 2012). Although, there are vast differences in the type of 
surgery performed (Nelson, 2009). 
Non-sterile sources are the main origin for contaminants causing SSI (Fossum, 2002). These 
contaminants often include the bacterial flora that normally inhabits the skin (Falk-Brynhildsen 
et al., 2013). Such bacteria include e.g.; Staphylococcus spp., Escherichia Coli, Pasteurella 
spp. and Bacteroides spp. (Sveriges veterinärförbund, 2009). Examples of non-sterile sources 
may be neglected surgical equipment, patients own surfaces and fluids (e.g. skin, 
gastrointestinal tract) (Sveriges veterinärförbund, 2009). Even though the skin is prepared with 
a sterile wash, it is not possible to remove every single bacterium from the skin (Falk-
Brynhildsen et al., 2013). These remaining bacteria can then be transferred to the surgical 
wound through the surgeon’s hands or instruments to cause a cross contamination and thus 
cause an infection (Falk-Brynhildsen et al., 2013). 
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A bacterial infection is defined as having more than 105 bacteria per gram of tissue (Robson et 
al., 1968; Fossum, 2002). Surgical wounds may be classified by the degree of contamination in 
order to predict the probability that a SSI will occur. Wounds can be classified by four different 
categories of contamination; a) clean, b) clean-contaminated, c) contaminated, d) dirty 
(Fossum., 2002; Sveriges veterinärförbund, 2009). Clean wounds include non-inflammatory, 
operative wounds that does not involve the respiratory-, gastrointestinal-, genitourinary- or the 
oropharyngeal tracts (Fossum, 2002). If one or more of the above tracts are included, the wound 
is classified as clean-contaminated wound. Therefore, clean-contaminated wounds are 
performed under controlled surgical conditions, and also comprises the placement of drains in 
clean wounds (Fossum, 2002; Sveriges veterinärförbund, 2009).  
Clean wounds have an SSI rate between 0-6% (Berzon, 1979; Vasseur et al., 1985; 1988; 
Eugster et al., 2004; Nelson, 2009; 2011; Fossum, 2009; Tobias et al., 2012). The rates increase 
when associated with severe traumas such as bone fractures (Fossum, 2002; Sveriges 
veterinärförbund, 2009). Contaminated wounds occur when the surgical asepsis is 
compromised by any contaminated fluid (e.g. spills of gastrointestinal content), but purulent 
discharge is not present (Fossum, 2002; Sveriges veterinärförbund, 2009). Wounds are 
classified as dirty, when purulent discharge, necrotic tissue or foreign bodies are present 
(Fossum, 2002; Sveriges veterinärförbund, 2009).  
 
Table 3. Incidence of SSI (apated and summarized from: Berzon, 1979; Vasseur et al., 1985; 1988; 
Eugster et al., 2004; Fossum, 2009; Nelson, 2009a; 2011b; Tobias et al., 2012) 
Wound classification SSI Incidence (%) 
Clean 0-6 
Clean-contaminated 3.5- 9.3 
Contaminated 4.6-26.8 
Dirty 6.7-18.1 
 
Risk factors for the development of SSI 
The development of SSI depends on external (e.g. bacterial strain) and intrinsic factors (e.g. 
immunological status, comorbidities and affected tissues). In addition to the surgical site 
conditions other factors such as hematoma, necrotic tissue and local infections can also 
influence the patient’s ability to withstand SSI. The reason being that these factors can inhibit 
the normal response from the host (Fossum, 2002; Sveriges veterinärförbund, 2009). 
Although the surgical technique may be immaculate, the outcome or possibility of 
complications also depend on the patient’s status. Physical condition, nutritional status, 
concurrent diseases or metabolic disorders and immunosuppressive medication all play a role 
in the development of SSI (Fossum, 2002). Furthermore, the possibility to keep the surgical 
wound in stillness to avoid tension, and also compliance from the owner concerning post-
operative care are important factors. 
Duration of surgery and anaesthesia are also contributing factors in the development of SSI. 
Higher complications rates (i.e. SSI) are observed in surgeries that lasts longer than 90 minutes 
and when anaesthesia lasts longer than 120 minutes (Vasseur et al., 1988; Eugster et al., 2004; 
Muraro et al., 2014).  
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Implants of different sorts may also be a risk factor (Arciola et al., 2012). Eventhough surgical 
asepsis is practiced, implants can be colonized by bacteria (Arciola et al., 2012). Implant 
surfaces can also function as a substrate for the development biofilm (Arciola et al., 2012). 
Bacteria embedded in biofilm are able to withstand the patient’s immune response and 
antibiotics (Arciola et al., 2012) 
The risk of hypothermia and hypovolemia during surgery should also be minimised since these 
factors can contribute to the development of post-operative complications (Sveriges 
veterinärförbund, 2009). Hypothermia and hypovolemia can impair peripheral circulation, thus 
reduce the resilience against possible infections (Heinzelmann et al., 2002; Sveriges 
veterinärförbund, 2009; Nelson, 2011). Therefore, patients should be carefully monitored 
concerning body temperature and also treated with intravenous fluids when necessary (Sveriges 
veterinärförbund, 2009). 
The surgeon’s technique regarding tissue handling is important as traumatized tissue supports 
bacterial growth (Nelson, 2011). 
Patients older than 10 years of age have an increased risk of developing SSI because of a 
possibly impaired immune response (Fossum, 2002). Also patients younger than one year of 
age may be predisposed because of an immature immune response (Fossum, 2002). 
 
Prevention of SSI 
Asepsis 
The ultimate goal of aseptic technique is to avoid infections during surgery. Aseptic technique 
is defined as “the methods and practices that prevent cross contamination in surgery” (Fossum, 
2002). There are a number of routines and preparations commonly used to avoid the occurrence 
of SSI. These routines include e.g. surgical hand wash (Widmer et al., 2010), preparation of the 
area of surgery (Noorani et al., 2010), sutures treated with antiseptic substances (Edmiston et 
al., 2006), surgical gloves (Hayes et al., 2014), protective gowns, surgical caps and mouth 
guards (Rutala et al., 2001), check lists (Weiser et al., 2010), surgical drapes of different kinds 
(Rutala et al., 2001) and also recommendations concerning the premises where the surgery is 
carried out (Sveriges veterinärförbund, 2009). 
 
Antibiotics 
 
Prophylactic use of antibiotics 
Antibiotics used prophylactically require a sufficient concentration at the surgical area when 
the procedure commences in order to inhibit the growth of potential pathogens (Fossum, 2002). 
Nevertheless, antibiotics should not be used to compensate poor surgical preparations or a faulty 
technique (Sveriges veterinärförbund, 2009). Antibiotics used for prophylactic treatment should 
be administered at least 30 minutes, but not more than 60 minutes before the initial incision 
(Sveriges veterinärförbund, 2009). The antibiotics, in this case, should be administered 
intravenously because subcutaneous or intramuscular administration does not give steady 
serum concentrations to the same extent as intravenously administration (Sveriges 
veterinärförbund, 2009). If the half-life (T½) is known, administration should be repeated after 
two T½ (Sveriges veterinärförbund, 2009). The optimal length for prophylactic treatment with 
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antibiotics has not been defined, but should cease at the end of surgery (Sveriges 
veterinärförbund, 2009).  
The type of antibiotic chosen for pre-operative therapy, should have a narrow spectrum of 
activity, it should be able to penetrate the area of incision and also be aimed at the bacteria that 
is expected to cause a possible infection (Sveriges veterinärförbund, 2009). 
Antibiotics recommended for prophylactic use during soft tissue and orthopaedic surgeries are 
penicillin (bensylpenicillin sodium, ampicillin, amoxicillin and cloxacillin) or 1st generations 
cephalosporins (cephalotin) (Sveriges veterinärförbund, 2009). 
 
Therapeutic use of antibiotics 
Generally, antibiotics are required to treat SSI. For this reason, the proper selection of antibiotic 
is of importance to avoid bacterial resistance (Fossum, 2002; Sveriges veterinärförbund, 2009). 
The choice of substance is preferably made by results of a bacterial culture (Sveriges 
veterinärförbund, 2009). Nevertheless, specific tissue affinity and minimal side effects should 
be considered (Fossum, 2002; Sveriges veterinärförbund, 2009). In addition to antibiotics, other 
options of treatment can be used, such as drains, lavage, removal of necrotic tissue and infected 
implants (Fossum, 2002). 
 
Antiseptics 
Antiseptics are biocides or products that can destroy or inhibit the growth of microrganisms in 
or on living tissue (McDonnell et al., 1999). Antiseptics differ from antibiotics by the ability of 
antibiotics to travel through the lymphatic system to destroy bacteria, and from disinfectants as 
the latter are used to destroy microorganisms found on non-living objects (McDonnell et al., 
1999). For an antiseptic to function satisfyingly it should meet numerous criteria. These criteria 
can differ depending on if they are meant to be used on healthy or, in anyway, compromised 
skin. For instance, the efficiency of antiseptics can be judged by their spectrum of effect or their 
antiseptic efficiency (Lachapelle et al., 2013). Furthermore, they can be classified by their time 
of action and skin interaction (Lachapelle et al., 2013). Antiseptics generally have a broad 
spectrum of antimicrobial activity, thus their use in connection to infections could reduce the 
usage of antibiotics and therefore minimize the risk of development of bacterial resistance 
(Lachapelle et al., 2013). 
 
Povidone iodine (PVP-I) 
Povidone iodine (PVP-I) is an iodine union which is efficient against both gram negative and 
gram positive bacteria, spores, fungi, protozoa and viruses (Lachapelle et al., 2013). PVP-I 
mechanism of action is through a slow release of idodine from the union, which leads to 
ionization of lipids and oxidation of cytoplasm and cell membranes without affecting the tissue 
of the patient (Lachapelle et al., 2013). 
PVP-I has the broadest antimicrobial spectrum of all available antiseptics (Lachapelle et al., 
2013). It also has a fast and long lasting effect and at the same time it is very well tolerated by 
the skin but may cause allergic reactions (Lachapelle et al., 2013). PVP-I is not associated with 
selection of resistant strains of bacteria (Lachapelle et al., 2013). In contrast to this, bacterial 
resistance for example chlorhexidine, silver and triclosan has been reported (Lachapelle et al., 
2013). 
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Triclosan 
Triclosan is an antiseptic which at very high concentrations has a bactericidal effect (Braoudaki 
et al., 2004). In contrast to most other antiseptics, it is very specific in its mechanism of action 
(Braoudaki et al., 2004). Triclosan binds to an enzyme that is coded for in the Fabl-gene and 
through a series of processes inhibits the synthesis of fatty acids that are needed for the 
reproduction of bacteria (Braoudaki et al., 2004). 
The Fabl-gene is also the target for many narrow spectrum antibiotics (Braoudaki et al., 2004). 
Because of this, it has been debated if the usage of triclosan can lead to the development of 
antibiotic resistance against the types of antibiotics that targets the same gene among these 
bacteria (Braoudaki et al., 2004). In a study it was shown that exposure to triclosan was linked 
to a high risk of development of resistance and cross-resistance among Staphylococcus aureus 
and Escherichia coli (Westgate et al., 2016). 
 
Chlorhexidine 
Chlorhexidine is considered to be a safe and well tolerated antiseptic, which has proven to be 
effective in reducing infections in both surgical and nonsurgical patients (George et al., 2016). 
It is effective against gram negative and gram positive bacteria, facultative anaerobes, some 
lipid-enveloped viruses as well as yeasts (Abbas et al., 2016; George et al., 2016). Chlorhexidin 
acts by altering the osmotic equilibrium in bacteria through binding to the cell wall (Milestone 
et al., 2010). Chlorhexidine also have a residual effect with a high level of antimicrobial activity 
for up to several hours after application and it has a strong affinity for skin and mucous 
membranes (George et al., 2016).  
The widespread use of chlorhexidine as an antiseptic agent does, however, raise concerns for 
resistance (Abbas et al., 2016). In Methicillin-resistant Staphylococcus aureus (MRSA) and 
Klebsiella spp. multidrug efflux systems have been identified to cause resistance against 
chlorhexidine (Abbas et al., 2016). 
In a study, the efficiency of a number of antiseptics was compared at different concentrations 
(Koburger et al., 2010). In said study triclosan, PVP-I, octenidine, polyhexanide and 
chlorhexidine was compared. The results showed that if a longer period of contact is possible 
(>24h) the efficiency of the different substances ranked as follows: 
 
Polyhexanide = octenidine > chlorhexidine > triclosan > PVP-I (Koburger et al., 2010). 
 
If a more rapid effect was desired, which is desired in pre-operative wash, the substances ranked 
as follows; 
 
Octenidine = PVP-I >> polyhexanide > chlorhexidine > triclosan (Koburger et al., 2010). 
 
According to the same study, PVP-I reached an acceptable antimicrobial activity after a contact 
time of 1 minute (Koburger et al., 2010). In contrast to this, chlorhexidine reached the same 
level of antimicrobial activity as PVP-I after 10 minutes (Koburger et al., 2010).  
A study analysed the optimal time that PVP-I should be left to dry prior to surgery to be as 
efficient as possible (Yasuda et al., 2015). The results showed that PVP-I was as most effective, 
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in minimizing the incidence of SSI, if it was allowed to dry for 10 minutes before the initial 
incision was made (Yasuda et al., 2015). 
Chlorhexidine solutions are often alcohol based and the drying time may vary. Generally, a 
drying time of 3 minutes is recommended for alcohol based solutions before the area is covered 
by surgical drapes (Cowles et al., 2014). Although, the drying time may differ when used in 
veterinary medicine. This is because animals often have more hair than humans which can 
affect the time it takes for alcohol based, chlorhexidine solutions to dry (Cowles et al., 2014). 
 
Surgical drapes 
Self-adherent surgical drapes were introduced in human medicine about 50 years ago (Falk-
Brynhildsen et al., 2013). Since then, they have been improved by being impregnated by various 
antiseptics such as PVP-I and triclosan. The purpose of these drapes is to reduce the number of 
SSI through minimizing the possibility of cross-contamination of the surgical wound. Several 
studies, including both animals and humans, have been carried out to analyse the functionality 
of these drapes. In a study, the results showed that the occurrence of SSI in surgeries, where an 
untreated adhesive drape was used to cover the surgical area, was in fact higher than the 
surgeries where no drape was used at all (Owen et al., 2009). Similar results were presented in 
a review article (Webster et al., 2013). According to Webster et al. (2013), the rates of SSI, 
after surgeries where an adhesive drape treated with PVP-I was used, was no different than the 
surgeries where no drape was used at all (Webster et al., 2013). 
 
Antimicrobial dressings 
The purpose of an antibacterial dressing is to lessen the bacterial burden of the wound (Mosti 
et al., 2015). The dressing should have a broad spectrum of effect at the same time as it should 
not damage the healthy skin or prolong wound healing (Mosti et al., 2015). Dressings can be 
treated with antiseptics that possess bactericidal effects or with hydrophobic substances (Mosti 
et al., 2015). As the bacteria causing SSI are often hydrophobic in nature, these bacteria bind 
to the hydrophobic dressing (Mosti et al., 2015; Stanirowski et al., 2016). When the dressing is 
changed, the bacterias bound to the dressing is removed from the wound along with it (Mosti 
et al., 2015; Stanirowski et al., 2016). 
Dressings treated with hydrophobic substances have the advantage of not releasing any 
antimicrobial substances (Stanirowski et al., 2016). Hence, the risk of cytotoxicity and 
sensitization is non existing (Stanirowski et al., 2016). Moreover, the risk of development of 
resistance among bacteria is eliminated, which is a cause for concern when using dressings 
treated with e.g. silver or triclosan (Braoudaki et al., 2004; Stanirowski et al., 2016). Along 
with minimal risks, hydrophobic dressings may also accelerate wound healing since they can 
stimulate fibroblast proliferation and migration (Cutting et al., 2015; Stanirowski et al., 2016). 
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Canine mammary tumors 
Mammary tumours are the most common type of tumour found in female dogs (Morris et al., 
2001; Henry et al., 2010). However, the term mammary tumour does include a wide range of 
different histological types (Table 4) (Bostock, 1986). Approximately 50% of the tumours that 
occur in the mammary glands are malignant (Morris et al., 2001). About half of the malign 
tumours are prone to metastasize (Henry et al., 2010). Although mammary tumours can occur 
in all breeds, there are some with a genetic predisposition, such as spaniels, miniature poodles, 
german sheperds, malteese, yorkshire terriers and dachshunds (Henry et al., 2010). Large 
breeds are more prone to develop malignant tumours than small breeds (Itoh et al., 2005; Henry 
et al., 2010; Komazawa et al., 2016). The majority of mammary tumours occur in animals over 
10 years of age (Morris et al., 2001). The development of mammary tumours is linked to 
oestrogen and progesterone levels (Morris et al., 2001). Therefore, the risk of developing 
mammary tumours increase with the number of oestrus cycles gone through (Morris et al., 
2001). Thus, it is well accepted that spaying female dogs before their second oestrus is 
protective against the development of malignant mammary tumours (Schneider et al., 1969; 
Murphy, 2008; Henry et al., 2010; Scmidt et al., 2015). 
The mammary gland is formed by epithelial ducts and alveoli located along stromal connective 
tissue. Around each and everyone of these alveoli there are myoepithelial cells (Morris et al., 
2001). Tumours that originate from the epithelial tissue are described as simple (epithelial 
elements only) or complex (mixed elements) (Morris et al., 2001). Benign tumours (e.g. lipoma) 
and malign tumours (e.g. mastocytoma) can also develop in the mammary tissue without being 
classified strictly as mammary tumours (Morris et al., 2001).  
Benign mammary tumours are classified as: a) simple adenomas, b) complex adenomas or, c) 
benign mesenchymal tumours (Morris et al., 2001). These benign tumours are minimally 
invasive and do not metastasize. However, excision of benign nodules from mammary tissue 
does not exclude the possibility of new benign tumours developing in the same gland at a later 
stage (Morris et al., 2001). Carcinomas make up about 90% of the malign tumours found in 
mammary tissue (Morris et al., 2001). The remaining 10% is made up of sarcomas and mixed 
malignant tumours (Morris et al., 2001). Carcinomas can vary from well circumscribed, small 
nodules to ulcerated, diffuse and inflamed (Morris et al., 2001). They can also be infiltrative 
masses that extend down into the inguinal region and down the hind-limbs (Morris et al., 2001). 
Malignant tumours can behave like benign tumours or in a more aggressive way (Morris et al., 
2001). Once a tumour is removed and analysed to be malignant, the most important trait is if it 
shows signs of local invasion (Morris et al., 2001). If this is the case, these tumours tend to 
invade local lymph nodes and lungs rapidly (Morris et al., 2001). Although lymph nodes and 
lungs are the most common locations for metastasis, it does not exclude the risk of metastasis 
to abdominal organs (Morris et al., 2001). 
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Table 4. Frequency of histological types of mammary tumours in dogs (adapted from: Bostock, 1986)  
Tumour type Relative frequency/ 
incidence (%) 
Benign 51.0 
Benign mixed tumours/ 
fibroadenomas, complex 
adenomas 
45.5 
Simple adenomas 5.0 
Benign mesenchymal 
tumours 
0.5 
Malignant 49.0 
Solid carcinomas 16.9 
Tubular carcinomas 15.4 
Papillary carcinomas 8.6 
Anaplastic carcinomas 4.0 
(Total carcinomas) 44.9 
Sarcomas 3.1 
Carcinosarcomas/ malignant 
mixed tumours 
1.0 
 
Methods of treatment 
Mastectomy is the gold standard of treatment for mammary gland tumours in dogs (Bartels et 
al., 1978; Novosad et al., 2003; Henry et al., 2010; Kudnig et al., 2012). Nonetheless, there are 
some exceptions such as inflammatory carcinomas (where surgery is contraindicated) or if 
metastasis in other organs are present, where chemotherapeutics may be indicated (Henry et al., 
2010; Kudnig et al., 2012). No chemotherapeutic protocol has been shown to improve the 
survival time for dogs with mammary tumours (Henry et al., 2010). Different chemotherapeutic 
agents have been used (e.g. paclitaxel, 5-FU, doxorubicin, carboplatine) but neither have been 
proven to be better than the other (Henry et al., 2010). Neither radiation therapy or 
immunotherapy have been explored well enough to show their importance in the treatment of 
mammary tumours in dogs (Henry et al., 2010). 
The choice of surgical approach depends on the size of the tumour, or tumours, and also 
localisation and invasiveness into underlying and/or surrounding tissue (Kudnig et al., 2012). 
Lumpectomy, (also known as nodulectomy), is a type of surgery performed on well 
circumscribed masses that are superficial and has a size smaller than 1 cm (Morris et al., 2001; 
Kudnig et al., 2012). Lumpectomy includes removing the nodule and a margin of about 1 cm 
of the skin that is surrounding the tumour (Kudnig et al., 2012). This technique involves 
removing only the tumour rather than removing the entire gland itself (Kudnig et al., 2012). 
Mastectomy (also known as mammectomy) includes the removal of an entire gland (Kudnig et 
al., 2012). This technique applies to tumours larger than 1 cm or if the tumour is invading the 
surrounding tissue (Kudnig et al., 2012). When this technique is chosen as the surgical 
approach, it is recommended that the gland is removed with a margin of 1-2 cm and also 
dissected down to the abdominal fascia (Kudnig et al., 2012). If the tumour is adherent to the 
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abdominal fascia, the part that is adherent to the tumour should also be removed (Kudnig et al., 
2012).  
The cranial thoracic, caudal thoracic and cranial abdominal gland (glands no. 1, 2 and 3) and 
the cranial abdominal, caudal abdominal and inguinal gland (glands no. 3, 4 and 5) have a large 
extent of lymphatic connections (Fig. 1) (Morris et al., 2001; Tobias et al., 2012). When one 
larger or several tumours are located in any one of these glands, the recommendation is to 
perform a regional mastectomy (Morris et al., 2001; 
Kudnig et al., 2012). A regional mastectomy implies 
the removal of all of the glands that share lymphatic 
connections (Kudnig et al., 2012). The inguinal lymph 
nodes also have a close connection to gland number 5 
and is usually removed along with the removal of this 
gland (Kudnig et al., 2012). The axillar lymph node, 
on the other hand, is somewhat difficult to reach and 
is seldom involved (Kudnig et al., 2012). For this 
reason, the axillar lymph node is often only removed 
if it shows signs of enlargement or if it shows 
cytological signs of metastasis (Kudnig et al., 2012). 
A radical mastectomy entails removing an entire 
chain of glands on one side (unilateral) or both sides 
(bilateral) (Kudnig et al., 2012). This type of radical 
surgery is performed on dogs with extensive disease 
(Kudnig et al., 2012). If removal of both sides is 
indicated this should be done during two separate 
surgeries with at least 3-6 weeks in between them 
(Kudnig et al., 2012). An elliptical incision is made 
along both sides of the chain witch a 1-2 cm margin 
(Kudnig et al., 2012). Like mastectomies and regional 
mastectomies, dissection down to the abdominal 
muscle fascia is performed and if the tumours are 
adherent to the fascia, this part of the fascia is also 
removed (Kudnig et al., 2012). 
Mammary gland 1-3 generally drains cranially and 
gland 4-5 generally drains caudally (Harvey et al., 
1998; Henry et al., 2010). Although gland 3 and 4 
may drain to either side (Harvey et al., 1998; Henry et 
al., 2010). In many cases there are also lymphatic 
communication between adjacent glands (Morris et al., 2001). Because of the lymphatic 
communication, glands adjacent to glands that contain tumours, and also entire chains of 
mammary glands in the individuals that suffer tumours in the third gland, sometimes need to 
be removed. Although this might be theoretically correct, there are no studies that support that 
this does affect the final outcome of future health in the dog (Morris et al., 2001). 
  
Fig. 1. Lymphatic drainage of canine mammary 
glands 
A. Axillary lymph nodes B. Inguinal lymph nodes 
1. Cranial thoracic gland (gland 1) 2. Caudal 
thoracic gland (gland 2) 3. Cranial abdominal 
gland (gland 3) 4. Caudal abdominal gland (gland 
4) 5. Inguinal gland (gland 5)  
Picture: Private.  
Schematic adapted from: Harvey et al., (1998) 
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MATERIAL AND METHODS 
Relevant data were collected from patient’s record database (at the University Animal Hospital, 
Uppsala, Sweden) in which a search was made for female dogs diagnosed with mammary 
tumors. Dogs that underwent surgery from July, 2013, to September, 2016 were evaluated. The 
chosen interval was set to be able to study one month post-operatively to evaluate post-operative 
complications and also to be as current as possible. The study group consisted of female dogs 
that were subjected to surgery to remove mammary tumours. Patients in the study group were 
confined to individuals between the ages of 3 to 10, weighing between 10 to 30 kg. Individuals 
with concurrent diseases or disorders such as lung metastasis, diabetes mellitus or various skin 
conditions were excluded from the study. Individuals that were treated with peri-operative 
antibiotics and/or glucocorticoids were also excluded. 
The surgical approach chosen for each individual patient was noted as well as the number of 
glands removed. The surgical wounds included in this study ranged from lumpectomies to 
radical mastectomies. They were all observed as separate wounds, without consideration given 
to the surgical approach or number of glands excised. If more than one wound was created in 
the same patient during the same surgery they were observed as separate wounds.  
 
Surgery 
In the case of lumpectomies, an incision was made over the tumour which was then excised 
with blunt and sharp dissection. In the case of more extensive surgery, an elliptical incision was 
made around the mammary glands to be excised and subcutaneously dissected with sharp and 
blunt dissection until the abdominal muscle fascia was exposed, and if necessary partially 
removed due to adherence to the tumour/tumours.  
Major blood vessels, including superficial epigastric vessels, were ligated with a 2-0 or a 3-0 
absorbable suture. Whenever the inguinal mammary gland was removed PDS or Monocryl (2-
0 or 3-0) was also used to advance the skin toward the centre of the defect with a walking suture 
and a subcuticular continuous suture. Simple interrupted or continuous sutures with a 3-0 or 2-
0 monofilament (nylon) suture were use to appose skin. The time of anaesthesia was defined 
from the time of induction to the time of extubation. 
 
Description of Data 
Data collected from the medical records included: incidence of complications (Table 6), breed 
(Attachement 1), age at time of surgery/surgeries (Attachment 2), weight, surgical 
approach/portion of mammary gland chain removed (Table 5) and pathologic analysis of the 
lesions that were removed (Attachment 3). In addition, evaluation of wound healing and the 
bacteriological cultures taken from the wounds with a suspected infection was studied along 
with the type of antibiotic used for treatment (Table 7). 
The type of pre-medication protocol was noted (Attachment 4), the type of suture material used 
in the subcutaneous and the cutaneous tissues (Attachment 5), if patients were treated with local 
anaesthesia or not (Attachement 6) and the substances used for post-operative pain relief 
(Attachment 7). 
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Anaesthesia 
In all of the surgeries, anaesthesia was induced by propofol and maintained with isoflurane in 
an inhalant anaesthesia machine. 
All the data collected from the patient records, concerning complications during wound healing 
was evaluated by a senior surgeon to distinguish SSI from other complications during wound 
healing. 
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RESULTS 
A total of 65 surgeries (ranging from lumpectomies to radical mastectomies) were performed 
on 59 dogs resulting in 95 separate wounds. 
In total (of the patients that were included in this study) nine patients were treated with 
antibiotics post-operatively due to suspicion of SSI. Two patients were diagnosed with a SSI 
post-operatively at an external clinic. These clinics were contacted with the owner’s permission. 
In one case there was an infection due to both haemolytic E. coli and Staphylococcus 
pseudointermedius and in the other case no culture was taken (Table 7). 
The nine patients with a suspected SSI, at the University Animal Hospital, had a bacteriological 
culture test including evaluation of antibiotic resistance analysed. Two of these cultures showed 
no growth, hence no infection was present. However, one infection was due to β-hemolytic 
streptococci, another due to Staphylococcus pseudointermedius, two due to both β-hemolytic 
streptococci and pseudointermedius, one due to Staphylococcus pseudointermedius and one 
due to Staphylococcus aureus. None of the cultures showed signs of antimicrobial 
multiresistance (Table 7). 
Out of the nine patients treated with antibiotics, seven recieved amoxicillin and two recieved 
clindamycin.  
Seven patients were excluded because of pre-operative medication. Out of these seven patients, 
five was treated with ampicillin and two were treated with prednisolone. 
Complications reported were divided into: seroma, infection, suture reaction, dehiscence/ 
wound rupture and other. The total complication rate in surgical wounds due to removal of 
mammary tumours was 20% and the infection rate was 7.4%. 
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Table 5. Total incidence (%) of complications in wounds divided by surgical approach 
Complication Lumpectomy  Regional mastectomy Radical 
mastectomy  1 gland 2 glands 3 glands 4 glands 
Seroma  0 0 16.6 18.2 0 0 
Infection 2.5 0 8.3 18.2 20 22.2 
Suture 
reaction  
0 5.5 0 9.1 0 0 
Dehiscence/ 
wound 
rupture  
0 0 8.3 18.2 20 11 
Other 0 0 0 18.2 0 0 
Number of 
wounds 
40 18 12 11 5 9 
 
Table 6. Total incidence (%) of complications in total amount of wounds (n=95) 
Complication Incidence (%) 
Seroma 4.2 
Infection  7.4 
Suture reaction  2.1 
Dehiscence/ wound rupture 4.2 
Other 2.1 
 
Table 7. Bacterial cultures from suspected SSI and choice of antibiotic 
Bacterial Culture Antibiotic 
Amoxicillin Clindamycin 
β-haemolytic Strept. 1  
Staph. pseudointermedius 1  
β-haemolytic Strept. & Staph. pseudointermedius 2  
Staph. aureus 1  
Haemolytic E. coli & Staph. pseudointermedius 1  
No growth 1 1 
N/a  1 
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DISCUSSION 
This is the first study analysing the need for treatment with antibiotics in connection to 
mastectomies that has been reported. Since mammary tumours are the most common tumour in 
female dogs, it is also a surgery that is commonly performed. Therefore, guidelines concerning 
the use of peri-operative antibiotics in connection to this procedure should be considered to be 
of great importance.  
Rather than sorting by amount of patients, sorting was done by amount of wounds created 
during surgery. The reason being that several individuals had multiple tumours surgically 
removed that was situated in glands not adjacent to one another. This resulted in several cases 
with more than one wound created in the same animal during the same surgery. 
Antibiotics should only be used when indicated or necessary. In these cases, the choice of 
antibiotic should, when possible, be based on a bacterial culture and resistance. Another factor 
that should be taken into consideration is that if the use of antibiotics is indicated, the substance 
should also have a minimal negative impact on the patient (Weese, 2008). Negative side effects 
of antibiotic treatment include e.g. diarrhea which, if severe, may affect the patient’s immune 
response in a negative way.  
If antibiotics are not used cautiously, the inevitable side effect is the progressive development 
of multiresistant bacteria (van den Bogaard et al., 2000). The worst case scenario includes the 
total unability to treat bacterial infections with antibiotics. Because of this, the author considers 
this study to be of importance. Similar studies analysing the need for antibiotics in connection 
to other common surgeries, procedures and conditions, without clear regimens for the use of 
antibiotics are equally important.  
In a study by Turk et al. (2015), the fact that procedure-specific studies are important is 
discussed. The authors argue that analysing risk factors for SSI for a diverse surgical population 
can limit the possibility to make conclusions (Turk et al., 2015). The risk is that procedure-
specific factors associated with SSI may be overlooked (Turk et al., 2015). 
The unnecessary use of antibiotics in veterinary medicine does not only affect animals. The 
development of resistance is not confined to clonal spread of resistant strains (van den Bogaard 
et al., 2000). Resistance can also be spread through the transfer of genes between animal and 
human bacteria (van den Bogaard et al., 2000). Although the threat of development of 
multiresistant bacteria is increasing due to over use of antibiotics it is still extensively misused. 
For the safety of public health, the selection and spread of resistant bacteria from animals must 
be controlled (van den Bogaard et al., 2000). This can only be achieved by reducing the amount 
of antibiotics used (van den Bogaard et al., 2000). 
One study suggested that wound classification should be considered for all surgical techniques 
to be able to determine appropriate pre-operative, intra-operative and post-operative care 
(Weese, 2008). 
 
Apart from the correct choice of antibiotics, the time of treatment is also of importance. As 
stated earlier, pre-operative antibiotics should be administered intravenously not less than 30 
minutes but not more than 60 minutes before surgery. One study showed that administration of 
antibiotics after surgery did not differ in preventing SSI compared to no peri-operative 
antibiotics at all (Stone et al., 1976). 
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When comparing the results concerning post-operative complications, specifically SSI, that 
afflicted the dogs included in this study to complications and SSI in animals included in other 
studies there were limitations. The guidelines for the use of antibiotics in Sweden are more 
restrictive than in many other countries where prophylactic antibiotics are used as a standard 
even in surgeries considered as clean. Because of this, comparison of SSI rates may be 
misguiding since the surgeries are performed during different conditions.  
At the same time as comparisons may be limited, the results when comparing the incidence of 
SSI becomes interesting. 
None of the patients included in this study recieved pre-operative antibiotics. The incidence of 
SSI was 7.4% (n=7/95). This is similar, or in some cases even lower, than several of the studies 
analysing the rates of SSI in clean, soft tissue, surgeries that included reconstruction and where 
patients recieved prophylactic antibiotics, sometimes broad spectrum (Muraro et al., 2014). 
Studies have shown that the use of prophylactic antibiotics did not influence the incidence of 
SSI in clean surgeries performed by experienced surgeons (Vasseur et al., 1985; 1988).  
According to Swedish guidelines, pre-operative antibiotics should only be administered in 
surgeries that are considered to be in the risk zone of developing a SSI (Sveriges 
veterinärförbund, 2009). Pre-operative antibiotics may also be used when, if an SSI would 
occur, the consequences of this is considered to be disastrous (Sveriges veterinärförbund, 2009).  
A study reported that the incidence of SSI was twice as high in surgeries that lasted 90 minutes 
when compared to surgeries that lasted 60 minutes (Brown et al., 1997). According to the model 
used in another study which intended to predict SSI, the risk increased 1.01 times per minute 
of surgery. This corresponded to a doubling of the risk of developing SSI per 70 minutes of 
surgery (Eugster et al., 2004). 
In a study including 377 dogs that underwent elective ovariohysterectomy (OHE) without pre-
operative antibiotics, the incidence of SSI (and suture abscesses) were 6% (23 dogs) (Berzon, 
1979). OHE is one of the most common elective procedures carried out on female dogs and is 
not an indication for prophylactic use of antibiotics (Berzon, 1979; Sveriges veterinärförbund, 
2009; Adin, 2011). Eventhough mastectomy is a reconstructive surgery and OHE is not, the 
two procedures share similarities in the surgical approach. They both include incisions in the 
same area of the body and the post-operative care is somewhat similar.  
OHE guidelines do not recommend the use of pre-operative antibiotics. Since OHE infection 
rates reported from Berzon (1979), and mastectomies, without treatment of prophylactic 
antibiotics, are similar they should be instituted similar pre-operative guidelines for the use of 
antibiotics. 
Mastectomy is considered as a clean surgery. Eventhough there are obvious risk factors for the 
development of SSI, such as large amount of dead space, wound tension and risk for necrosis, 
it should not be classified as a surgery in which prophylactic antibiotics are necessary in an 
otherwise healthy dog. Instead, in surgeries, such as mastectomy, where one is aware of the 
possible risk factors, extra care should be given to preparation, technique and duration of the 
surgery. The major limitation of this study lies in the retrospective evaluation of the clinical 
reports concerning wounds and distinguishing SSI from other complications concerning wound 
healing. The (relative) size of the wounds and effect thereof was not analysed. The different 
conditions in the home environment for each of the patients and compliance from the owner are 
also inherent limitations to this study. 
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CONCLUSIONS 
The results from this study, indicates that the rate of SSI in mastectomies is not higher than the 
rates in other clean surgeries. This study presents no evidence that supports prophylactic use of 
antibiotics in mastectomies. 
Antibiotics should never compensate for a faulty preparation or surgical technique. Since the 
use of antibiotics in clean surgeries have been studied in numerous studies, and been proven 
not to reduce the rates of SSI, they should only be used if clearly indicated. 
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ATTACHEMENTS 
Attachement 1 
Complications divided by breed 
Breed Complication Total  
Seroma Infection Suture 
reaction 
Wound rupture/ 
Dehiscence 
Other 
Airedale terrier 1     1 
American cocker 
spaniel 
     1 
Bavarian mountain 
scenthound 
     1 
Havanese      1 
Mixed breed  2    11 
Border collie 1     2 
Border terrier      1 
English cocker 
spaniel 
   1  3 
Danish-swedish 
farmdog 
     1 
Dobermann 1   1  1 
English bulldog     1 1 
English setter  1    1 
English springer 
spaniel 
     2 
Finnish lapphund      1 
Flat coated retriever      1 
Golden retriever   1   2 
Swedish elkhound 1   1  1 
German short-
haired pointingdog 
     2 
Labrador retriever  1    5 
Lagotto romagnolo      2 
Münsterlander  1    1 
Nova scotia duck 
tolling retriever 
     3 
Spanish waterdog      1 
Pumi      1 
Schnauzer      1 
German shepherd      3 
Siberian husky      1 
Staffordshire bull 
terrier 
    1 1 
Standard poodle      2 
Swedish lapphund      1 
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Tibetan terrier  1 1   1 
Welsh springer 
spaniel 
 1  1  2 
 
Attachement 2 
Complications divided by age at time of surgery 
Age Complication Surgeries 
performed at 
age 
Seroma Infection Suture 
reaction 
Wound rupture/ 
Dehiscence 
Other 
3-<4      1 
4-<5 1  1 1 1 6 
5-<6      4 
6-<7     1 9 
7-<8 2 2  1  10 
8-<9 1 3 1 1  19 
9-10  2  1  16 
 
Attachement 3 
Complications divided by tumour type 
Tumour type Complication Total 
amount of 
tumours 
Seroma Infection Suture 
reaction 
Wound 
rupture/ 
dehiscence 
Other 
Adenoma  2 1 1  23 
Carcinoma 1 2  2  9 
Mixed adenoma/ 
carcinoma 
 1    6 
Unknown benign      5 
Unknown malign 1 1  1  4 
Other   1   4 
n/a 2 1   2 14 
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Attachement 4 
Complications divided by type of pre medication (when generic name of substance was given this is 
noted, when substance name was given this is noted) 
Pre medication Complication Total 
amount of 
pre med.* 
protocol 
Seroma Infection Suture 
reaction 
Wound ruptue/ 
dehiscence 
Other 
Acepromazine, 
Butorphanol 
     1 
Acepromazine, 
Carprofen, Methadone 
1 2  2  23 
Acepromazine, 
Carprofen, Methadone, 
Medetomidine 
  1   1 
Acepromazine, 
Medetomidine 
 1    1 
Acepromazine, 
Meloxicom, Methadone 
1     6 
Acepromazine, 
Methadone 
1     8 
Glycopyrrolate, 
Acepromazine, 
Carprofen, Methadone 
     1 
Medetomidine, 
Butorphanol 
     1 
Medetomidine, 
Butorphanol, Carprofen 
     2 
Medetomidine, 
Methadone 
     2 
Medetomidine, 
Methadone, Carprofen 
 2    5 
Medetomidine, 
Methadone, 
Glycopyrrolate 
    1 1 
Medetomidine, 
Methadone, Norocarp 
     1 
Buprenorfine, 
Methadone, Carprofen 
     1 
Plegicil, Methadone      3 
Plegicil, Norocarp, 
Methadone 
     1 
Robinul, Plegicil, 
Methadone 
    1 1 
Robinul, Plegicil, 
Norocarp, Methadone 
     2 
                                                 
* Pre  
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Sedator, Norocarp, 
Methadone 
 1 1   1 
Unknown 1 1  2  3 
 
Attachement 5 
Complications divided by suture material (sut. mat.) used in sub cutis (s.c.) and cutis (c.) 
Suture material  
(s.c.; c.) 
Complication Amount of 
surgeries 
where sut. 
mat. used 
Seroma Infection Suture 
reaction 
Wound rupture/ 
Dehiscence 
Other 
Ethilon (size n/a)      1 
Monocryl 3-0; Ethilon 
3-0 
2 1  2 1 13 
Monocryl 3-0; 
Monocryl 3-0 
     13 
Monocryls 3-0; 
Monocryl 3-0  
(+ Tegaderm) 
 1    1 
Monocryl 4-0; 
Monocryl 4-0 
     3 
PDS 2-0;  
Ethilon 3-0 
 1  1 1 5 
PDS 2-0, Monocryl 3-0; 
Ethilon 3-0 
1 2    10 
PDS 2-0, Monocryl 3-0; 
Monocryl 3-0 
     1 
PDS 3-0;  
Ethilon 3-0 
1 1 1   5 
PDS 3-0; Monocryl 3-0      1 
PDS 3-0, Monocryl 3-0; 
Ethilon 3-0 
 1 1 1  6 
PDS 3-0, Monocryl 3-0; 
Ethilon 3-0 
(+Tegaderm) 
     2 
PDS 3-0, Monocryl 4-0; 
Monocryl 4-0 
     1 
PDS 2-0, Monocryl 3-0,  
Ethilon (size n/a) 
     1 
Vicryl 3-0;  
Ethilon 3-0 
     1 
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Attachement 6 
Complications divided by the use (and substance) of local anaesthesia (when generic name of substance 
was given this is noted, when substance name was given this is noted) 
Substance Complication Total 
Seroma Infection Suture 
reaction 
Wound rupture/ 
dehiscence 
Other 
Lidocaine + Bupivacaine  1    5 
Marcaine      1 
Marcaine + Lidocaine 1     2 
Xylocaine      1 
Xylocaine + Marcaine      1 
None 3 6 2 4 2 55 
 
Attachement 7 
Complications divided by substances used for post-operative (post op.) pain relief (when generic name 
of substance was given this is noted, when substance name was given this is noted) 
Post op.  Complication Total 
amount of 
post op. 
protocol 
Seroma Infection Suture 
reaction 
Wound rupture/ 
dehiscence 
Other 
Carprofen      1 
Durogesic patch     1 2 
Durogesic patch & 
Norocarp 
     3 
Durogesic patch & 
Metacam 
 1  1  6 
Durogesic patch & 
Rimadyl 
1 2  1  6 
Marcain drain & 
Durogesic patch 
 1    1 
Metacam 1 2    11 
Methadone      1 
Norocarp  1 1 1 1 14 
Rimadyl 1  1   11 
Temgesic & Norocarp      1 
Tramadol      1 
Unknown NSAID      1 
n/a 1   1  6 
 
